Robert Balazs
Overview
Explore the profile of Robert Balazs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papp O, Jordan V, Hetey S, Balazs R, Kaszas V, Bartha A, et al.
NPJ Syst Biol Appl
. 2024 Aug;
10(1):83.
PMID: 39117666
No abstract available.
2.
Papp O, Jordan V, Hetey S, Balazs R, Kaszas V, Bartha A, et al.
NPJ Syst Biol Appl
. 2024 Jun;
10(1):68.
PMID: 38906870
Combination therapy is well established as a key intervention strategy for cancer treatment, with the potential to overcome monotherapy resistance and deliver a more durable efficacy. However, given the scale...
3.
Bettencourt C, Miki Y, Piras I, de Silva R, Foti S, Talboom J, et al.
Neuropathol Appl Neurobiol
. 2020 Dec;
47(5):640-652.
PMID: 33368549
Aims: Multiple system atrophy (MSA) is a fatal neurodegenerative disease. Similar to Parkinson's disease (PD), MSA is an α-synucleinopathy, and its pathological hallmark consists of glial cytoplasmic inclusions (GCIs) containing...
4.
Balazs R
Degener Neurol Neuromuscul Dis
. 2020 Jul;
4:85-102.
PMID: 32669903
The worldwide increase in life expectancy is leading to an increase in age-dependent diseases, including nonfamilial, sporadic Alzheimer's disease (AD), which is the subject of this review. The etiology and...
5.
Bettencourt C, Piras I, Foti S, Talboom J, Miki Y, Lashley T, et al.
Acta Neuropathol Commun
. 2020 May;
8(1):71.
PMID: 32410669
No abstract available.
6.
Bettencourt C, Foti S, Miki Y, Botia J, Chatterjee A, Warner T, et al.
Acta Neuropathol
. 2019 Sep;
139(1):135-156.
PMID: 31535203
Multiple system atrophy (MSA) is a fatal late-onset neurodegenerative disease. Although presenting with distinct pathological hallmarks, which in MSA consist of glial cytoplasmic inclusions (GCIs) containing fibrillar α-synuclein in oligodendrocytes,...
7.
Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease
Lashley T, Gami P, Valizadeh N, Li A, Revesz T, Balazs R
Neuropathol Appl Neurobiol
. 2014 Sep;
41(4):497-506.
PMID: 25201696
Aims: Genetic factors do not seem to account fully for Alzheimer disease (AD) pathogenesis. There is evidence for the contribution of environmental factors, whose effect may be mediated by epigenetic...
8.
Balazs R, Reynolds E
J Hist Neurosci
. 2013 Apr;
22(2):199-207.
PMID: 23586549
No abstract available.
9.
Bokkon I, Erdofi-Szabo A, Till A, Balazs R, Sarosi Z, Szabo Z, et al.
Electromagn Biol Med
. 2012 Jun;
31(4):394-403.
PMID: 22676138
Recently, we published our results (Bókkon et al., 2011. Electromagn Biol Med.) regarding the effectiveness of the EMOST (Electro-Magnetic-Own-Signal-Treatment) method for the reduction of phantom limb pain under clinical circumstances....
10.
Balazs R, Vernon J, Hardy J
Neurobiol Aging
. 2011 Jun;
32(7):1181-7.
PMID: 21669333
The interesting review from Mastroeni and colleagues highlights recent progress on epigenetic analysis of Alzheimer's disease, but it also illustrates how much we still need to do.